These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 31277995

  • 1. ICU Interventions in Ischemic Stroke Patients Treated Using Liberalized IV-tPA Criteria.
    Murray NM, Ke M, Yee A, Chen C, Wong C, Bedenk A, Fernandes J, Barazangi N, Tong D.
    J Stroke Cerebrovasc Dis; 2019 Sep; 28(9):2488-2495. PubMed ID: 31277995
    [Abstract] [Full Text] [Related]

  • 2. Generalized Safety and Efficacy of Simplified Intravenous Thrombolysis Treatment (SMART) Criteria in Acute Ischemic Stroke: The MULTI SMART Study.
    Sørensen SB, Barazangi N, Chen C, Wong C, Grosvenor D, Rose J, Bedenk A, Morrow M, McDermott D, Hove JD, Tong DC.
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1110-1118. PubMed ID: 26897101
    [Abstract] [Full Text] [Related]

  • 3. Atherosclerotic intracranial internal carotid artery calcification and intravenous thrombolytic therapy for acute ischemic stroke.
    Gocmen R, Arsava EM, Oguz KK, Topcuoglu MA.
    Atherosclerosis; 2018 Mar; 270():89-94. PubMed ID: 29407893
    [Abstract] [Full Text] [Related]

  • 4. Ten-Year Evaluation of the TOYOTA Prehospital Stroke Scale for Tissue Plasminogen Activator Intravenous Therapy in the Real World.
    Suzuki J, Nakai N, Kondo N, Tsuji H, Inagaki R, Furukawa S, Iwata M, Nishida S, Ito Y.
    Cerebrovasc Dis; 2018 Mar; 46(3-4):184-192. PubMed ID: 30384371
    [Abstract] [Full Text] [Related]

  • 5. Safety and Outcomes of Intravenous tPA in Acute Ischemic Stroke Patients With Prior Stroke Within 3 Months: Findings From Get With The Guidelines-Stroke.
    Shah S, Liang L, Kosinski A, Hernandez AF, Schwamm LH, Smith EE, Fonarow GC, Bhatt DL, Feng W, Peterson ED, Xian Y.
    Circ Cardiovasc Qual Outcomes; 2020 Jan; 13(1):e006031. PubMed ID: 31903770
    [Abstract] [Full Text] [Related]

  • 6. Intravenous Tissue Plasminogen Activator for Wake-Up Stroke: A Propensity Score-Matched Analysis.
    Anaissie JE, Monlezun DJ, Siegler JE, Waring ED, Dowell LN, Samai AA, George AJ, Kimbrough T, Berthaud J, Martin-Schild S.
    J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2603-2609. PubMed ID: 27476340
    [Abstract] [Full Text] [Related]

  • 7. Preclusion of ischemic stroke patients from intravenous tissue plasminogen activator treatment for mild symptoms should not be based on low National Institutes of Health Stroke Scale Scores.
    Wendt M, Tütüncü S, Fiebach JB, Scheitz JF, Audebert HJ, Nolte CH.
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):550-3. PubMed ID: 23433783
    [Abstract] [Full Text] [Related]

  • 8. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals.
    Schwamm LH, Ali SF, Reeves MJ, Smith EE, Saver JL, Messe S, Bhatt DL, Grau-Sepulveda MV, Peterson ED, Fonarow GC.
    Circ Cardiovasc Qual Outcomes; 2013 Sep 01; 6(5):543-9. PubMed ID: 24046398
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Critical Care Needs in Patients with Diffusion-Weighted Imaging Negative MRI after tPA--Does One Size Fit All?
    Faigle R, Marsh EB, Llinas RH, Urrutia VC.
    PLoS One; 2015 Sep 01; 10(10):e0141204. PubMed ID: 26517543
    [Abstract] [Full Text] [Related]

  • 11. Low-Dose Tissue Plasminogen Activator in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
    Cheng JW, Zhang XJ, Cheng LS, Li GY, Zhang LJ, Ji KX, Zhao Q, Bai Y.
    J Stroke Cerebrovasc Dis; 2018 Feb 01; 27(2):381-390. PubMed ID: 29111341
    [Abstract] [Full Text] [Related]

  • 12. Derivation and Validation of a Scoring System for Intravenous Tissue Plasminogen Activator Use in Asian Patients.
    Yeo LLL, Chien SC, Lin JR, Liow CW, Lee JD, Peng TI, Luen TH, Sharma V, Chan B, Lee TH, SRICHS Group.
    J Stroke Cerebrovasc Dis; 2017 Aug 01; 26(8):1695-1703. PubMed ID: 28408066
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Barriers to the use of intravenous tissue plasminogen activator for in-hospital strokes.
    Bunch ME, Nunziato EC, Labovitz DL.
    J Stroke Cerebrovasc Dis; 2012 Nov 01; 21(8):808-11. PubMed ID: 21640608
    [Abstract] [Full Text] [Related]

  • 16. Utilization of intravenous tissue plasminogen activator for ischemic stroke: are there sex differences?
    Allen NB, Myers D, Watanabe E, Dostal J, Sama D, Goldstein LB, Lichtman JH.
    Cerebrovasc Dis; 2009 Nov 01; 27(3):254-8. PubMed ID: 19176959
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Intravenous tPA for Acute Ischemic Stroke in Patients with COVID-19.
    Carneiro T, Dashkoff J, Leung LY, Nobleza COS, Marulanda-Londono E, Hathidara M, Koch S, Sur N, Boske A, Voetsch B, Aboul Nour H, Miller DJ, Daneshmand A, Shulman J, Curiale G, Greer DM, Romero JR, Anand P, Cervantes-Arslanian AM.
    J Stroke Cerebrovasc Dis; 2020 Nov 01; 29(11):105201. PubMed ID: 33066885
    [Abstract] [Full Text] [Related]

  • 19. Neutrophil-to-Lymphocyte Ratio and Response to Intravenous Thrombolysis in Patients with Acute Ischemic Stroke.
    Pektezel MY, Yilmaz E, Arsava EM, Topcuoglu MA.
    J Stroke Cerebrovasc Dis; 2019 Jul 01; 28(7):1853-1859. PubMed ID: 31072698
    [Abstract] [Full Text] [Related]

  • 20. Isolated Sulcal Effacement and Response to Intravenous Thrombolysis in Acute Ischemic Stroke.
    Pektezel MY, Arsava EM, Gocmen R, Topcuoglu MA.
    J Stroke Cerebrovasc Dis; 2020 Oct 01; 29(10):105168. PubMed ID: 32912520
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.